Sofwave Receives FDA Clearance for Treating Upper Arm Skin Laxity
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
For patients considering or undergoing plastic and reconstructive surgery procedures, using social media to gather information and answer questions can enhance patient empowerment—potentially leading to increased autonomy and better decision-making, reports a study in the April issue of Plastic and Reconstructive Surgery.